Ironwood Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-40
Closed -$3K 276
2021
Q3
$3K Hold
40
﹤0.01% 469
2021
Q2
$3K Hold
40
﹤0.01% 464
2021
Q1
$3K Hold
40
﹤0.01% 450
2020
Q4
$2K Hold
40
﹤0.01% 438
2020
Q3
$3K Hold
40
﹤0.01% 363
2020
Q2
$3K Hold
40
﹤0.01% 344
2020
Q1
$3K Buy
+40
New +$2.76K ﹤0.01% 298
2015
Q3
$2K Hold
21
﹤0.01% 329
2015
Q2
$2K Hold
21
﹤0.01% 296
2015
Q1
$2K Sell
21
-1
-5% -$102 ﹤0.01% 292
2014
Q4
$2K Buy
+22
New +$2.27K ﹤0.01% 252

Other funds holding GILD

Ironwood Financial's GILD Position: Q4 2021 in Review

Ironwood Financial sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 40 shares — an estimated $3K sold.

Ironwood Financial first reported a position in GILD in Q4 2014 and held it in 11 quarters. The position peaked at $3K in Q3 2021. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Ironwood Financial reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Ironwood Financial sold 40 Gilead Sciences shares in Q4 2021, an estimated $3K.
  • Ironwood Financial first reported a position in Gilead Sciences in Q4 2014 and held it in 11 quarters.
  • Ironwood Financial's Gilead Sciences position peaked at $3K in Q3 2021.
  • 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.